| Product Code: ETC8549424 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Spinal Muscular Atrophy Treatment Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Spinal Muscular Atrophy Treatment Market - Industry Life Cycle |
3.4 Netherlands Spinal Muscular Atrophy Treatment Market - Porter's Five Forces |
3.5 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By TreatmentTreatment, 2021 & 2031F |
3.7 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By TreatmentDrug, 2021 & 2031F |
3.8 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Netherlands Spinal Muscular Atrophy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about spinal muscular atrophy (SMA) and its treatment options in the Netherlands |
4.2.2 Advances in medical research leading to the development of innovative SMA treatments |
4.2.3 Supportive government initiatives and policies promoting access to SMA treatments |
4.3 Market Restraints |
4.3.1 High treatment costs associated with SMA therapies limiting affordability for patients |
4.3.2 Limited availability of specialized healthcare facilities for SMA treatment in the Netherlands |
4.3.3 Regulatory challenges and delays in the approval process for new SMA treatments |
5 Netherlands Spinal Muscular Atrophy Treatment Market Trends |
6 Netherlands Spinal Muscular Atrophy Treatment Market, By Types |
6.1 Netherlands Spinal Muscular Atrophy Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 1, 2021- 2031F |
6.1.4 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 2, 2021- 2031F |
6.1.5 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 3, 2021- 2031F |
6.1.6 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 4, 2021- 2031F |
6.2 Netherlands Spinal Muscular Atrophy Treatment Market, By TreatmentTreatment |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.3 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Drug, 2021- 2031F |
6.3 Netherlands Spinal Muscular Atrophy Treatment Market, By TreatmentDrug |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Spinraza, 2021- 2031F |
6.3.3 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Zolgensma (AVXS-101), 2021- 2031F |
6.3.4 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Evrysdi, 2021- 2031F |
6.3.5 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Spinal Muscular Atrophy Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Netherlands Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Injection, 2021- 2031F |
7 Netherlands Spinal Muscular Atrophy Treatment Market Import-Export Trade Statistics |
7.1 Netherlands Spinal Muscular Atrophy Treatment Market Export to Major Countries |
7.2 Netherlands Spinal Muscular Atrophy Treatment Market Imports from Major Countries |
8 Netherlands Spinal Muscular Atrophy Treatment Market Key Performance Indicators |
8.1 Patient enrollment in SMA clinical trials in the Netherlands |
8.2 Number of SMA treatment centers and specialized healthcare professionals in the country |
8.3 Adoption rates of emerging SMA treatment modalities |
8.4 Research and development investment in SMA treatment options |
8.5 Patient satisfaction and quality of life improvements post-treatment |
9 Netherlands Spinal Muscular Atrophy Treatment Market - Opportunity Assessment |
9.1 Netherlands Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Netherlands Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By TreatmentTreatment, 2021 & 2031F |
9.3 Netherlands Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By TreatmentDrug, 2021 & 2031F |
9.4 Netherlands Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Netherlands Spinal Muscular Atrophy Treatment Market - Competitive Landscape |
10.1 Netherlands Spinal Muscular Atrophy Treatment Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Spinal Muscular Atrophy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here